Pan-cancer analysis showed that WDR62 was highly expressed in a variety of tumors, and similarly, the expression level of WDR62 in ovarian cancer was significantly higher than that in normal ovaries in the TCGA-GTEx dataset, GSE26712, GSE12470, and GSE18520 datasets. The gene discussed is WDR62; the disease is cancer.